COL4A1/2-related familial vascular leukoencephalopathy Advocacy Hub | UniteRare

At a Glance

Live from database

1 event

Oct 1999

Aromasin: FDA approved

Treatment of advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy.

FDAcompleted

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

1 program

FINANCIAL LANDSCAPE SUMMARY

Total programs

Open now

Patient Assistance Programs1

Aromasin

Pharmacia & Upjohn

OpenContact for details

No active clinical trials currently recruiting for COL4A1/2-related familial vascular leukoencephalopathy.
Search all trials →

No recent news articles indexed yet for COL4A1/2-related familial vascular leukoencephalopathy.
Search PubMed for COL4A1/2-related familial vascular leukoencephalopathy →

No specialists currently listed for COL4A1/2-related familial vascular leukoencephalopathy.

View Disease Page

Full profile, treatments, community

Search Clinical Trials

Find recruiting studies now

Find Specialists

Ranked by expertise & trials

Financial Assistance

Copay cards, PAPs, grants